SCHEDULE 13D/A

NovaBay Pharmaceuticals Inc

Common Stock, $0.01 par value · CUSIP: 66987P409

Event date: 2025-10-16

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• R01 Fund LPReported CIK 0001990517

  Shares: 56,806,080.00 · Class: 45.1%

• R01 Capital LLC

  Shares: 56,806,080.00 · Class: 45.1%

• R01 Capital Manager LLC

  Shares: 56,806,080.00 · Class: 45.1%

• Michael Kazley

  Shares: 56,806,080.00 · Class: 45.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.